Literature DB >> 15046679

Androgen-deprivation therapy for prostate cancer.

Celestia Higano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15046679     DOI: 10.1016/s1540-0352(11)70015-4

Source DB:  PubMed          Journal:  Clin Prostate Cancer        ISSN: 1540-0352


× No keyword cloud information.
  4 in total

1.  Acceptability of Fitbit for physical activity tracking within clinical care among men with prostate cancer.

Authors:  Dori Rosenberg; Elyse A Kadokura; Erin D Bouldin; Christina E Miyawaki; Celestia S Higano; Andrea L Hartzler
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

2.  Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer.

Authors:  Cordula A Jilg; Anja Leifert; Daniel Schnell; Simon Kirste; Natalia Volegova-Neher; Daniel Schlager; Gesche Wieser; Karl Henne; Wolfgang Schultze-Seemann; Anca-L Grosu; Hans Christian Rischke
Journal:  Radiat Oncol       Date:  2014-08-12       Impact factor: 3.481

3.  Psychometric properties of the German version of the Self-Image Scale (SIS-D).

Authors:  Jan Brederecke; Jennifer L Scott; Martina de Zwaan; Elmar Brähler; Frank Neuner; Michael Quinn; Tanja Zimmermann
Journal:  PLoS One       Date:  2020-03-16       Impact factor: 3.240

4.  Psychometric properties of the German version of the Self Image Scale (SIS-D) in a sample of cancer patients.

Authors:  Jan Brederecke; Tanja Zimmermann
Journal:  PLoS One       Date:  2020-10-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.